FY23 beckman reagents SVC okinawa

Ended Purchase Order Awarded Last action

Contract number
HT941023P0001
Awardee
Awarding agency
Obligated
$1,096,381

Award facts

Opportunity
Contract value 62% obligated
  • $1,357,318.70 Current, with exercised options
  • $1,762,578.38 Potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Japan

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00014 $1,352
Funding Only Action P00013 $341,477
Supplemental Agreement for work within scope P00012 · Beckman reagents for military treatment facility yokosuka, japan. $0
Other Administrative Action P00011 · Reagent supplies. $0
Supplemental Agreement for work within scope P00010 · Beckman reagents for iwakuni -$260,938
Supplemental Agreement for work within scope P00009 · Beckman reagents iwakuni $394,399
Supplemental Agreement for work within scope P00008 · FY25 beckman reagents SVC. Yokosuka -$329,878
Supplemental Agreement for work within scope P00007 · Beckman reagents SVC. $106,564
Supplemental Agreement for work within scope P00006 · FY24 beckman reagents SVC. Yokosuka $112,487
Supplemental Agreement for work within scope P00005 · Beckman reagents for yokosuka $0
Supplemental Agreement for work within scope P00004 · Beckman reagents service -$10,426
Supplemental Agreement for work within scope P00003 · Beckman reagents service. Yokosuka $83,695
Funding Only Action P00002 · FY24 beckman reagents SVC. Yokosuka $599,729
Supplemental Agreement for work within scope P00001 · Beckman coulter hematology analyzer reagents $0
Original award $57,920
Show all 15

About this award

The Defense Health Agency awarded a firm fixed-price purchase order valued at $1.76M to Beckman Coulter K.K. for the provision of Beckman reagents supporting military treatment facilities in Okinawa and Yokosuka, Japan. The contract, awarded May 3, 2023, extends through September 30, 2027, and involves the supply of consumable reagents for hematology analyzers serving U.S. military medical laboratories in the Pacific region. This award was issued without a set-aside designation and represents a continuation of the Defense Health Agency's established relationship with Beckman Coulter K.K., a Tokyo-based subsidiary of Danaher Corporation specializing in medical diagnostic equipment and related services.

The originating solicitation, posted in September 2022, indicated the Defense Health Agency's intent to negotiate on a sole-source basis with Beckman Coulter for seven hematology analyzers across multiple military medical facilities with staged delivery through 2024 and optional extensions through September 2028. While this specific purchase order focuses on reagent supply, it supports the broader equipment procurement outlined in the solicitation and demonstrates the Defense Health Agency's reliance on Beckman Coulter's proprietary consumables and maintenance capabilities to sustain critical clinical laboratory operations at Naval Hospital Yokosuka and associated branch health clinics throughout Japan and Diego Garcia.

Quick answers

Who was awarded contract HT941023P0001?

HT941023P0001 was awarded to Beckman Coulter K.K. by Defense Health Agency (Department of Defense) on May 3, 2023.

How much is contract HT941023P0001 worth?

The government has obligated $1,096,381 on HT941023P0001. Its current value, with exercised options, is $1,357,319. Its potential value, with all options, is $1,762,578.

Was contract HT941023P0001 competed?

The extent of competition for HT941023P0001 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award